Molecular features of endometrial metaplastic processes, the risk factors for cancer relapse and neoplastic transformation


Endometrial metaplasia
Stem cell

How to Cite

Turashvili , T. ., Tevdorashvili , G. ., & Burkadze , G. (2022). Molecular features of endometrial metaplastic processes, the risk factors for cancer relapse and neoplastic transformation: Critical Review. Georgian Scientists, 4(1), 137–146.


Endometrial Metaplasia is the process in which normal endometrioid glands are undergoing replacement by other types of benign epithelium. Endometrium can show us a diversity of metaplastic changes. Modified differentiation of Endometrial cells can be due to the presence of degenerative/reparative, hormonal or neoplastic processes. The presence of Epithelial Metaplasia can signify other concomitants benign and malignant processes. Endometrial metaplasia can be either a single process or present with other histopathological changes. There are different types of endometrial metaplasia but the most common is tubal metaplasia. The second most common can be squamous metaplasia, transitional cell metaplasia, arias-Stella reaction/changes, cellular eosinophilic changes and mucinous metaplasia. different types of metaplasia can show us the various type and intensities of expression for P16, Cyclin E, Cyclin A, Ki67, B catenin, ER, CDX2, CD10, P63. The role and importance of distinct types of endometrial metaplasia in the relapse of cancer and neoplastic progression are still unknown. There is the clinical opinion that behind every single metaplastic process there is stem cell reprogramming but the phenomenon of endometrial metaplasia needs more thorough studies.


Travaglino A, Inzani F, Santoro A, Arciuolo D, Piermattei A, Pasquini S, Scaglione G, D'Alessandris N, Valente M, Raffone A, Fanfani F, Zannoni GF. Endometrial Metaplastic/Reactive Changes Coexistent with Endometrial Hyperplasia and Carcinoma: A Morphological and Immunohistochemical Study. Diagnostics (Basel). 2021 Dec 28;12(1):63. doi: 10.3390/diagnostics12010063. PMID: 35054228; PMCID: PMC8774443.

Lax SF. Vorläuferläsionen der Endometriumkarzinome [Precursor lesions of endometrial carcinoma]. Pathologe. 2019 Feb;40(1):13-20. German. doi: 10.1007/s00292-019-0568-5. PMID: 30707274.

Horree N, Heintz AP, Sie-Go DM, van Diest PJ. p16 is consistently expressed in endometrial tubal metaplasia. Cell Oncol. 2007;29(1):37-45. doi: 10.1155/2007/868952. PMID: 17429140; PMCID: PMC4618010.

Terada T. Extensive squamous metaplasia (morules) of the otherwise normal endometrium: a case report with immunohistochemical studies. Int J Clin Exp Pathol. 2013;6(3):543-5. Epub 2018 Feb 15. PMID: 23413394; PMCID: PMC3563190.

Bhardwaj N, Diwaker P, Gogoi P, Wadhwa N, Mishra K. Ichthyosis Uteri Associated with Endometrial Adenocarcinoma: A Case Report. J Clin Diagn Res. 2017;11(6):ED24-ED25. doi:10.7860/JCDR/2017/27951.10116

Ardighieri L, Palicelli A, Ferrari F, et al. Endometrial Carcinomas with Intestinal-Type Metaplasia/Differentiation: Does Mismatch Repair System Defects Matter? Case Report and Systematic Review of the Literature. J Clin Med. 2020;9(8):2552. Published 2020 Aug 6. doi:10.3390/jcm9082552

Levine, Douglas A. "Integrated genomic characterization of endometrial carcinoma." Nature 497.7447 (2013): 67-73.

Travaglino, A., Raffone, A., Russo, D. et al. Does endometrial morular metaplasia represent odontogenic differentiation? Virchows Arch 479, 607–616 (2021).

Yoo, S., Park, B., Choi, J. et al. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol 25, 1496–1507 (2012).

Liu, Q., Wu, Q., Yu, M. et al. Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis. Virchows Arch 475, 201–209 (2019).

Ip, P.PC. Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimens. Virchows Arch 472, 907–917 (2018).

Santoro, A., Travaglino, A., Inzani, F. et al. Clear cell endometrial carcinoma precursors: presentation of two cases and diagnostic issues. Diagn Pathol 16, 95 (2021).

Moritani S, Kushima R, Ichihara S, Okabe H, Hattori T, Kobayashi TK, Silverberg SG. Eosinophilic cell change of the endometrium: a possible relationship to mucinous differentiation. Mod Pathol. 2005 Sep;18(9):1243-8. doi: 10.1038/modpathol.3800412. PMID: 15803181.

Ismail, S. M. "Pathology of endometrium treated with tamoxifen. Journal of clinical pathology 47.9 (1994): 827-833.

McCluggage WG, McBride HA. Papillary syncytial metaplasia associated with endometrial breakdown exhibits an immunophenotype that overlaps with uterine serous carcinoma. Int J Gynecol Pathol. 2012 May;31(3):206-10. doi: 10.1097/PGP.0b013e31823bb1a1. PMID: 22498936.

Park CK, Yoon G, Cho YA, Kim HS. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience. Oncotarget. 2016 Jun 28;7(26):39197-39206. doi: 10.18632/oncotarget.10049. PMID: 27322430; PMCID: PMC5129925.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2022 Teona Turashvili , George Tevdorashvili , George Burkadze


Download data is not yet available.


Metrics Loading ...